Advertisement

Personalised Care and Research

  • David Strain
Chapter

Abstract

  • Diabetes management is a rapidly changing environment

  • Older adults are routinely excluded from clinical trial programs

  • Evaluation of the results of clinical trials and the applicability to the population that we work with is a skill in its own right

  • This chapter details a systematic approach to evaluating data from these clinical trials and how to apply it to the population that we work with.

  • Finally, it will review the difference between personalisation and individualisation in the application of treatments to improve outcomes for the people with diabetes

References

  1. Cruz-Jentoft AJ, Carpena-Ruiz M, Montero-Errasquín B, Sánchez-Castellano C, Sánchez-García E (2013) Exclusion of older adults from ongoing clinical trials about type 2 diabetes mellitus. J Am Geriatr Soc 61(5):734–738CrossRefPubMedGoogle Scholar
  2. Delgado J, Masoli JAH, Bowman K, Strain WD, Kuchel GA, Walters K, Lafortune L, Brayne C, Melzer D, Ble A, As part of the Ageing Well Programme of the NIHR School for Public Health Research, England (2017) Outcomes of treated hypertension at age 80 and older: cohort analysis of 79,376 individuals. J Am Geriatr Soc 65(5):995–1003CrossRefPubMedGoogle Scholar
  3. Friedman SM, Shah K, Hall WJ (2015) Failing to focus on healthy aging: a frailty of our discipline? J Am Geriatr Soc 63(7):1459–1462CrossRefPubMedGoogle Scholar
  4. Gaede P, Lund-Andersen H, Parving HH, Pedersen O (2008) Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 358(6):580–591CrossRefGoogle Scholar
  5. Kamel HK, Iqbal MA (2001) Body mass index and mortality among hospitalized elderly patients. Arch Intern Med 161(11):1459–1460CrossRefPubMedGoogle Scholar
  6. Strain WD, Lukashevich V, Kothny W, Hoellinger MJ, Paldánius PM (2013) Individualised treatment targets for elderly patients with type 2 diabetes using vildagliptin add-on or lone therapy (INTERVAL): a 24 week, randomised, double-blind, placebo-controlled study. Lancet 382(9890):409–416CrossRefPubMedGoogle Scholar
  7. Strain WD, Cos X, Hirst M, Vencio S, Mohan V, Vokó Z, Yabe D, Blüher M, Paldánius PM (2014) Time to do more: addressing clinical inertia in the management of type 2 diabetes mellitus. Diabetes Res Clin Pract 105(3):302–312CrossRefPubMedGoogle Scholar
  8. Strain WD, Agarwal AS, Paldánius PM (2017) Individualizing treatment targets for elderly patients with type 2 diabetes: factors influencing clinical decision making in the 24-week, randomized INTERVAL study. Aging (Albany NY) 9(3):769–777Google Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.University of Exeter Medical SchoolExeterUK

Personalised recommendations